Healthcare Technology - INDUSTRY NEWS

Share

TMCNet:  Research and Markets: Anti-Infectives - Global Strategic Business Report

[March 10, 2010]

Research and Markets: Anti-Infectives - Global Strategic Business Report

DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/976f21/antiinfectives) has announced the addition of the "Anti-Infectives - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Anti-Infectives in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period 2006 through 2015. The report profiles 77 companies including many key and niche players worldwide such as Abbott Laboratories, Alcon Pharmaceuticals Ltd., Astellas Pharma, Inc., AstraZeneca PLC , Bayer HealthCare AG , Bristol-Myers Squibb Co., Boehringer Ingelheim, Cubist Pharmaceuticals, Inc., Daiichi Sankyo Company, Limited, Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline PLC, . F. Hoffmann-La Roche, Ltd., Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Sanofi-Aventis SA, and Wyeth Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. Executive Summary 1. MARKET OVERVIEW & DYNAMICS 2. ANTI-BACTERIALS MARKET 3. ANTI-VIRALS MARKET 4. ANTI-FUNGALS MARKET 5. AN OVERVIEW OF VACCINES MARKET 6. RESEARCH & DEVELOPMENT 7. PRODUCT LAUNCHES 8. RECENT INDUSTRY ACTIVITY 9. DRUG APPROVALS 10. FOCUS ON SELECT GLOBAL PLAYERS 11. GLOBAL MARKET PERSPECTIVE III. MARKET IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 77 (including Divisions/Subsidiaries - 85) Some Companies Mentioned: Abbott Laboratories (USA) Alcon Pharmaceuticals Ltd. (Switzerland) Astellas Pharma, Inc. (Japan) AstraZeneca PLC (UK) Bayer HealthCare AG (Germany) Bristol-Myers Squibb Co. (USA) Boehringer Ingelheim (Germany) Cubist Pharmaceuticals, Inc. (USA) Daiichi Sankyo Company, Limited (Japan) Eli Lilly and Company (USA) Gilead Sciences, Inc. (USA) GlaxoSmithKline PLC (UK) F. Hoffmann-La Roche, Ltd. (Switzerland) Johnson & Johnson (USA) Merck & Co., Inc (USA) Novartis AG (Switzerland) Pfizer, Inc. (USA) Sanofi-Aventis SA (France) Wyeth Pharmaceuticals, Inc. (USA) For more information visit http://www.researchandmarkets.com/research/976f21/antiinfectives

[ Back To HealthTechZone.com's Homepage ]

Featured White Paper

Six Things Hospitals Need to Know About Supporting the Adoption of Smartphones

Pagers have been an essential part of healthcare communications for a long time due to their ability to provide reliable communications at a low cost. When pagers emerged on the healthcare scene, they fundamentally changed the way doctors, nurses, and administrators could be notified that... DOWNLOAD NOW >>

FREE eNewsletter

Click here to receive your targeted Healthcare Technology Community eNewsletter.
[Subscribe Now]